Add BrightSurf on Google Email

The Lancet


The Lancet Diabetes & Endocrinology: Gradual weight loss no better than rapid weight loss for long-term weight control

A new study published in The Lancet Diabetes & Endocrinology found that gradual weight loss is not more effective than rapid weight loss for achieving long-term weight control. In the trial, participants who lost weight quickly were more likely to achieve target weight loss and had lower drop-out rates.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateOct 15, 2014

The Lancet Diabetes & Endocrinology: Genetic study casts further doubt that vitamin D prevents the development of type 2 diabetes

A large genetic study has found no evidence of a causal link between vitamin D levels and the development of type 2 diabetes. The study, conducted by scientists at the University of Cambridge, examined the genes that control blood levels of vitamin D and found no association with the risk of developing type 2 diabetes.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateSep 30, 2014

The Lancet: Combining gut hormone with insulin proves more effective at controlling type 2 diabetes than other common treatments

A systematic review and meta-analysis found that combining basal insulin with a GLP-1 agonist resulted in improved blood sugar control, similar rates of hypoglycaemia, and greater weight loss compared to other anti-diabetic treatments. This combination therapy showed a 92% greater likelihood of achieving target blood sugar control.

SourceThe Lancet·JournalThe Lancet·DateSep 11, 2014

The Lancet Diabetes & Endocrinology: 1 in 4 people with diabetes worldwide live in China, but a new approach could help transform their care

A collaborative registry and community support approach could improve diabetes care in China, where 12% of adults have diabetes and half are at risk of prediabetes. The disease is linked to cardiovascular disease, chronic kidney disease, and cancer unless effective national intervention prevents it.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateSep 10, 2014

The Lancet Respiratory Medicine: Radiological correlates and clinical implications of the paradoxical lung function response to β2 agonists

A new observational study investigates the prevalence of paradoxical bronchoconstriction after using β2 agonists in smokers and ex-smokers with Chronic Obstructive Pulmonary Disease (COPD). The study reveals that African-American patients are twice as likely to experience a paradoxical response, leading to worse respiratory outcomes.

SourceThe Lancet·JournalThe Lancet Respiratory Medicine·DateSep 9, 2014

The Lancet Diabetes & Endocrinology: Global epidemic of diabetes threatens to jeopardise further progress in tuberculosis control

A new series published in The Lancet Diabetes & Endocrinology finds that the growing global diabetes epidemic is hampering progress in controlling and eliminating tuberculosis. With over 1 million cases annually, diabetes-associated TB cases are expected to offset the present downward trend in global TB cases by 8% or more by 2035.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateSep 3, 2014

The Lancet Respiratory Medicine: Household air pollution puts more than 1 in 3 people worldwide at risk of ill health and early death

A third of the world's population uses plant-based solid fuels for cooking, heating, and lighting, resulting in high levels of household air pollution. The Commission concludes that an estimated 600-800 million families worldwide are at increased risk of illnesses such as respiratory tract infections and lung cancer.

SourceThe Lancet·JournalThe Lancet Respiratory Medicine·DateSep 2, 2014

The Lancet: China-themed issue

China's rapid emergence as a global power has coincided with unprecedented challenges to its people's health, including rising chronic disease burdens and inefficient healthcare delivery. China must act now to tackle these time-bombs of illnesses or face the huge toll of largely preventable health loss suffered by high-income countries.

SourceThe Lancet·JournalThe Lancet·DateAug 28, 2014

The Lancet: European Society of Cardiology Congress media alert

Research highlights the effectiveness of blood pressure-lowering treatment based on cardiovascular risk, as well as the importance of predicted baseline risk equations. Additionally, studies investigate the use of bivalirudin versus heparin in percutaneous coronary intervention and implant-based multiparameter telemonitoring for heart ...

SourceThe Lancet·JournalThe Lancet·DateAug 14, 2014

The Lancet Psychiatry: reclassification of PTSD diagnosis potentially excludes soldiers diagnosed under previous criteria

A new study found that the reclassification of PTSD diagnosis in DSM-5 potentially excludes soldiers who were previously diagnosed under previous criteria. The authors surveyed 1822 US soldiers and found that just under a third were excluded when using DSM-5 criteria, highlighting concerns for treatment and benefits.

SourceThe Lancet·JournalThe Lancet Psychiatry·DateAug 13, 2014

The Lancet Diabetes & Endocrinology: 2 out of every 5 Americans expected to develop type 2 diabetes during their lifetime

A major study estimates that nearly half of the US adult population will develop type 2 diabetes by age 20, with Hispanic men and non-Hispanic black women facing the highest risk. The study found a significant increase in lifetime risk of diabetes over 26 years, driven by rising rates and longer life expectancy.

SourceThe Lancet·JournalThe Lancet Diabetes & Endocrinology·DateAug 12, 2014

The Lancet: Causes of death shifting in people with HIV

A large international study has found that overall death rates among HIV-positive adults have almost halved since 1999, while deaths due to AIDS-related causes and cardiovascular disease have declined significantly. Non-AIDS cancers remain a leading cause of non-AIDS deaths in people with HIV.

SourceThe Lancet·JournalThe Lancet·DateJul 17, 2014